Manulife (Manufacturers Life Insurance)’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.74M Buy
153,512
+51,696
+51% +$1.13M ﹤0.01% 1372
2025
Q4
$2.78M Sell
101,816
-8,268
-8% -$233K ﹤0.01% 1395
2025
Q3
$3.33M Buy
110,084
+87,525
+388% +$2.79M ﹤0.01% 1332
2025
Q2
$603K Buy
+22,559
New +$608K ﹤0.01% 2083

Other funds holding CAI

Manulife (Manufacturers Life Insurance)'s CAI Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Caris Life Sciences (CAI) stake by 51% in Q1 2026, buying an estimated $1.13M and bringing the position to 153,512 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1372.

Manulife (Manufacturers Life Insurance) first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.33M in Q3 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 153,512 shares of Caris Life Sciences worth $2.74M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 51,696 Caris Life Sciences shares in Q1 2026, an estimated $1.13M.
  • Caris Life Sciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1372 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Caris Life Sciences position peaked at $3.33M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.